Cannabis flowers are indispensable – why a ban would be harmful

Quick overview

• Fast & controllable: Inhaled flowers take effect in minutes – crucial for acute pain, cramps, and nausea. 

• Legally permissible: are in Germany dried flowers, Extracts and Dronabinol/Nabilone Prescribable – with clear G-BA rules.

• Political initiatives: Current drafts aim to restrict telemedicine/shipping, among other things; some even propose a Flower ban demanded – associations warn. 

• Supply reality: The need is great: in 2024 >72 t Flowers imported for medical/scientific purposes. 

1) Medical necessity: Why flowers must remain

1.1 Fast, titratable effect (minutes instead of hours)

For inhaled dose THC levels and effects increase significantly faster than with oral ingestion. Studies show that vaporization produces stronger pharmacodynamic effects at the same dose than smoking; overall, the effect within minutes (peak 15–30 min), duration often 2–4 h. For Breakthrough pain, spastic cramps, Migraine or Chemotherapy-induced nausea this is clinically relevant. 

1.2 Inhalation without combustion = fewer pollutants

Vaporizers deliver active ingredients without combustion and thus reduce pyrolysis products compared to smoking. Classic studies with medical vaporizers (e.g. Volcano) have already proven this Harm reduction benefitCurrent reviews of cannabis vaporization confirm the basic principle. 

1.3 Customizability & Entourage Effects

Flowers form the complete phytocomplex profile (Cannabinoids, terpenes, flavonoids). Doctors can Strain, THC/CBD range and terpene profile patient-specific and adjust the dose via train frequency/temperature finely titrate – something that standardized, purely oral preparations can only achieve to a limited extent. (The evidence for the "entourage hypothesis" is heterogeneous; clinical experience and patient-reported outcomes nevertheless support its benefit in individual cases.)

2) Legal situation & care in Germany (as of 2025)

• Prescribable are: dried flowers, Extracts and finished medicinal products Dronabinol/Nabilone. First prescription/fundamental change of therapy: Cashier approval required; subsequent regulations usually without further approval. 

• MedCanG 2024 The regulation relieved organisational burdens; in parallel, Import quantities strong (need for care). 

• KBV note: Finished medicines have priority before flowers – but Flowering plants remain permitted if there is a medical justification (e.g., the need for a rapid, easily controllable effect). This is important for therapeutic sovereignty. 

3) Political debate: What is currently being discussed

• BMG draft bill (2025): Personal doctor contact is mandatory, Shipping banRestrictions on telemedicine/e-prescriptions for medical cannabis. Criticized due to supply barriers and EU legal concerns. 

• “Blossom ban” as an idea: Some stakeholders are calling for the banning of flower-based drugs; industry and professional associations are warning of massive disadvantages for patients (delayed effects, reduced controllability, and diversion to unofficial channels).

Evaluation: Instead of blanket bans, we need indication- and patient-oriented decisionsA blanket ban would particularly affect patients who are fast-acting, flexible application.

4) Evidence Update: What Studies Say about Inhalation & Vaporizer

Important: The overall evidence on efficacy in individual indications is heterogeneous; this is precisely why more research – not fewer treatment options.

5) Why extract flowers not fundamentally replace

1. Onset & Controllability: Oral extracts take 30–90 minutes to take effect—poor for breakthrough situations; inhaled flower takes effect in minutes. 

2. Fine titration: With the flowering, the Dose in small steps adapt to your daily form/pain peaks.

3. Compatibility & Preference: Many patients report fewer side effects and better everyday control with flowering (clinical practice reports, PROs).

4. Therapy sovereignty: Guardrails (KBV/G-BA) yes – blanket bans no. Doctors must be able to choose on a case-by-case basis.

6) Risks of a prohibition/restriction policy

• Supply bottlenecks & delays (Practice routes, pharmacy requirement without mail order, less telemedicine). 

• Pushing into unofficial markets in cases of acute pain when legal, rapid options are lacking.

• Inequality (Urban vs. rural): Patients with long journeys are hit harder.

• Loss of trust into an already fragile supply – and thus poorer adherence.

7) Practical: How patients use flowers responsibly (with medical supervision)

• Application: Vaporizer instead of smoking (healthier, more discreet, more precise). 

• Setting: Our preview of low temperature start, increase slowly; on Symptom diary set (onset, duration, side effects).

• Combination: In chronic cases, if necessary. oral (basal level) + inhalation (breakthrough) – medical planning.

• Compliance & Security: Do not participate in road traffic while under acute influence; check for interactions; conduct regular follow-up checks.

8) Policy recommendations

• Flowers preserved – as a clearly justifiable option for rapid, titratable relief.

• Ensure quality – Laboratory controls, standardization, devices with reliable temperature control.

• Facilitating care – digital consultation hours and structured delivery routes for suitable cases instead of blanket bans.

• Promote research – Indication-specific RCTs, real-world data & registries.

FAQ

Are cannabis flowers permitted as medicine in Germany?
Yes. dried flowers, Extracts and Dronabinol/NabiloneSpecific G-BA rules apply to initial/follow-up prescriptions. 

Do flowers really work faster than drops/capsules?
Yes. Inhalation leads to Minutes to measurable effects; oral takes 30–90 min. – for breakthrough situations the difference is clinically relevant. 

Is vaping healthier than smoking?
Heating vaporizers without combustion → fewer pollutants than with a joint. 

What does the new draft change?
Planned are, among others: Obligation to contact a doctor personally and Shipping banExperts criticise this as being hostile to healthcare provision and partly questionable under EU law. 

Conclusion

Cannabis flowers are not a relic – they are medically necessary.
they offer fast, finely controllable Relief and enable a individualized Therapy where oral medications are too slow or difficult to titrate. A blanket ban would deprive patients of real options, worsen care, and undermine therapeutic sovereignty. The right approach is educate, ensure quality and improve evidence-based – not prohibit.